Beam Therapeutics Inc. - 21 Jun 2021 Form 4 Insider Report for Verve Therapeutics, Inc. (VERV)

Role: 10%+ Owner
Signature: /s/ Christine Bellon, SVP and CLO
Issuer symbol: VERV
Transactions as of: 21 Jun 2021
Net transactions value: $0
Form type: 4
Filing time: 23 Jun 2021, 16:30:16 UTC
Previous filing: 16 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VERV	Common Stock	Conversion of derivative security		+270,895	+98%		546,970	21 Jun 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VERV	Series A Convertible Preferred Stock	Conversion of derivative security		-2,508,361	-100%		0	21 Jun 2021	Common Stock	270,895		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Beam Therapeutics Inc. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	The convertible preferred stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share, on a 9.2595-for-1 basis immediately prior to the closing of the Issuer's initial public offering. The preferred stock had no expiration date.